Back

Impact of post-percutaneous mitral balloon valvuloplasty mitral valve area indexed for the body size on long-term outcomes in rheumatic mitral stenosis: a 20-year retrospective analysis.

26 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Rheumatic valve disease: spotlighting a forgotten disease Mitral Valve Stenosis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Thammarak Songsangjinda

Prince of Songkla University, Hat Yai (Thailand)

7 More presentations in this session

Presentation thumbnail
Prevalence, pattern and trend of rheumatic heart disease in a tertiary hospital in Nigeria: A 12-year retrospective echocardiographic study
Doctor T. Shogade (Uyo, NG)
Abstract Slides Video
Presentation thumbnail
A new regional Rheumatic Heart Disease Registry: results of the first 2595 patients
Doctor S. Kotit (Aswan, EG)
Abstract Slides Video
Presentation thumbnail
Degenerative or rheumatic: after all, what is the most prevalent etiology of mitral regurgitation in developing countries?
Mrs L. Vicente Pereira Lipari (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Left atrial strain and risk of systemic embolic event in rheumatic mitral stenosis with sinus rhythm
Professor I. Cho (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Thirty-year follow-up of patients submitted to percutaneous balloon mitral valvuloplasty for severe rheumatic mitral stenosis
Doctor S. Jacinto (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Rheumatic valve disease: spotlighting a forgotten disease

The Event

Event poster

ESC Congress 2023

26 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Session
Advanced echocardiography for risk stratification in valve disease
thumbnail
Congress Session
Improving prognosis after TAVI
thumbnail
Congress Presentation
Post-procedural in-hospital, short and long-term outcomes of transcatheter (percutaneous) versus surgical approach for management of patients with non-rheumatic mitral valve stenosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources